Determination of cilostazol and its active metabolite 3,4-dehydro cilostazol from small plasma volume by UPLCâMS/MS

Determination of cilostazol and its active metabolite 3,4-dehydro cilostazol from small plasma volume by UPLCâMS/MS

A simple, rapid and sensitive ultra performance liquid chromatography-tandem mass spectrometry (UPLCâMS/MS) method has been developed for the simultaneous determination of cilostazol and its pharmacologically active metabolite 3,4-dehydro cilostazol in human plasma using deuterated analogs as intern...

Full description

Bibliographic Details
Main Authors:	Nejal M. Bhatt, Vijay D. Chavada, Daxesh P. Patel, Primal Sharma, Mallika Sanyal, Pranav S. Shrivastav
Format:	Article
Language:	English
Published:	Elsevier 2015-02-01
Series:	Journal of Pharmaceutical Analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2095177914000689

Similar Items

A validated UPLCâMS/MS method for simultaneous determination of imatinib, dasatinib and nilotinib in human plasma
by: Jing Zeng, et al.
Published: (2017-12-01)

Improved simultaneous quantitation of candesartan and hydrochlorthiazide in human plasma by UPLCâMS/MS and its application in bioequivalence studies
by: Bhupinder Singh, et al.
Published: (2014-04-01)

Rapid sensitive validated UPLCâMS method for determination of venlafaxine and its metabolite in rat plasma: Application to pharmacokinetic study
by: Sunil Kumar Dubey, et al.
Published: (2013-12-01)

Development of a UPLCâMS/MS method for determination of pimavanserin tartrate in rat plasma: Application to a pharmacokinetic study
by: Shixiao Wang, et al.
Published: (2017-12-01)

Application of UPLCâMS/MS for separation and quantification of 3Î±-Hydroxy Tibolone and comparative bioavailability of two Tibolone formulations in healthy volunteers
by: Vijay P. Shinde, et al.
Published: (2013-08-01)

Simultaneous determination of human plasma protein binding of bioactive flavonoids in Polygonum orientale by equilibrium dialysis combined with UPLCâMS/MS
by: Yong Huang, et al.
Published: (2013-10-01)

Simultaneous analysis of aliskiren and hydrochlorothiazide in pharmaceutical preparations and spiked human plasma by HPTLC
by: Jui J. Pandya, et al.
Published: (2017-09-01)

Effect of Baicalein on the Pharmacokinetics of Cilostazol and Its Two Metabolites in Rat Plasma Using UPLC-MS/MS Method
by: Qinghua Weng, et al.
Published: (2022-04-01)

Development of a sensitive and rapid method for quantitation of (S)-(â)- and (R)-(+)-metoprolol in human plasma by chiral LCâESIâMS/MS
by: Primal Sharma, et al.
Published: (2014-02-01)

Determination of lercanidipine in human plasma by an improved UPLC–MS/MS method for a bioequivalence study
by: Darshan V. Chaudhary, et al.
Published: (2016-04-01)

Efficacy of cilostazol in canine bradyarrhythmia
by: Takahiro Ohmori, et al.
Published: (2022-08-01)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
by: Kenjiro Ono, et al.
Published: (2019-05-01)

A fast, sensitive and validated technique for eurycomanone and cordycepin quantitation using UPLCaEuro'MS/MS
by: Chua, Lee Suan, et al.
Published: (2018)

Cilostazol for the prevention of pneumonia: a systematic review
by: Hirotaka Nakashima, et al.
Published: (2018-04-01)

Effect of cilostazol on arteriovenous fistula in hemodialysis patients
by: Jae Wan Jeon, et al.
Published: (2021-11-01)

Effect of cilostazol on arteriovenous fistula in hemodialysis patients
by: Jae Wan Jeon, et al.
Published: (2021-11-01)

Safety and efficacy of cilostazol in the management of intermittent claudication
by: Yung-Wei Chi, et al.
Published: (2008-12-01)

Cilostazol for secondary stroke prevention: systematic review and meta-analysis
by: Leonard LL Yeo, et al.
Published: (2021-02-01)

Sensitive and rapid determination of amantadine without derivatization in human plasma by LC–MS/MS for a bioequivalence study
by: Abhaysingh Bhadoriya, et al.
Published: (2018-06-01)

Cilostazol: Several issues to be considered about the safety profile
by: Hiroshi Ito
Published: (2023-09-01)

Cilostazol: Several issues to be considered about the safety profile
by: Hiroshi Ito
Published: (2023-09-01)

5. THE EFFECT OF CILOSTAZOL TO ARTERIAL STIFFNESS IN THE HYPERTENSIVE PATIENT
by: Jin Oh Na, et al.
Published: (2009-10-01)

Allium sativum Compared to Cilostazol as an Inhibitor of Myointimal Hyperplasia
by: Paulo Roberto da Silva Lima, et al.

Cardioprotective Effect of Cilostazol on Ischemia-Reperfusion Injury Model
by: Mazlum Sahin, et al.
Published: (2021-12-01)

Management of peripheral arterial disease in the elderly: focus on cilostazol
by: Travis M Falconer, et al.
Published: (2008-03-01)

Cilostazol, um inibidor da fosfodiesterase III: perspectivas futuras na aterosclerose Cilostazol, a phosphodiesterase III inhibitor: future perspectives in atherosclerosis
by: Marcelo Pereira da Rosa, et al.
Published: (2006-11-01)

Pharmacological Prevention of Ectopic Erythrophagocytosis by Cilostazol Mitigates Ferroptosis in NASH
by: Joon Beom Park, et al.
Published: (2023-08-01)

Combination of cilostazol and clopidogrel attenuates Rat critical limb ischemia
by: Sheu Jiunn-Jye, et al.
Published: (2012-08-01)

Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?
by: George Galyfos, et al.
Published: (2017-09-01)

Pre-treatment with sumatriptan for cilostazol induced headache in healthy volunteers
by: Katrine Falkenberg, et al.
Published: (2018-08-01)

Cilostazol attenuates ovariectomy-induced bone loss by inhibiting osteoclastogenesis.
by: Ke Ke, et al.
Published: (2015-01-01)

Cilostazol prevents endothelin-induced smooth muscle constriction and proliferation.
by: Yoshifumi Kawanabe, et al.
Published: (2012-01-01)

Effect of cilostazol in experimental model of degloving injuries in rat limbs
by: André Pazio, et al.
Published: (2018-04-01)

POS-569 EFFECT OF CILOSTAZOL ON ARTERIOVENOUS FISTULA IN HEMODIALYSIS PATIENTS
by: J.W. Jeon, et al.
Published: (2021-04-01)

Application of an LC–MS/MS method for the analysis of amlodipine, valsartan and hydrochlorothiazide in polypill for a bioequivalence study
by: Jaivik V. Shah, et al.
Published: (2017-10-01)

An improved LC-MS/MS method for the quantification of alverine and para hydroxy alverine in human plasma for a bioequivalence study☆
by: Dhiraj M. Rathod, et al.
Published: (2017-04-01)

Preparation and in-vitro evaluation of cilostazol self-emulsifying drug delivery system
by: Ali N. Wannas, et al.
Published: (2020-06-01)

Peripheral Nerve Denervation in Streptozotocin-Induced Diabetic Rats Is Reduced by Cilostazol
by: Kuang-Yi Tseng, et al.
Published: (2023-03-01)

Inhibition of Phosphodiesterase 3A by Cilostazol Dampens Proinflammatory Platelet Functions
by: Daniëlle M. Coenen, et al.
Published: (2021-08-01)

Physiologically based absorption modeling to predict the bioequivalence of two cilostazol formulations
by: Lu Wang, et al.
Published: (2023-11-01)